What your blood type means and why it matters for donation and research
Learn how ABO and Rh blood types work, how common each type is, and why donors are essential for lifesaving care and medical research.
CGT Global donors are compensated from $25 and up to $1,000 for your time and effort depending on your donation type.
What Your Blood Type Means and Why It Matters for Cell Isolation and Research
Learn how ABO and Rh blood types work, how common each type is, and why well characterized donors are essential for cell isolation programs and biomedical research.
Important note about how CGT Global uses donated blood
CGT Global does not collect blood for transfusion or blood bank distribution. Blood donated through CGT Global is used as starting material to isolate cells for biomedical research and cell based therapy development.
CGT Global donors are compensated from $25 up to $1,000 for their time and participation depending on donation type and program needs.
What Determines Your Blood Type
Your blood type is determined by two main classification systems.
ABO System
The ABO system is based on the presence or absence of A and B antigens on the surface of red blood cells.
Type A has A antigens
Type B has B antigens
Type AB has both A and B antigens
Type O has neither A nor B antigens
Rh Factor
The Rh factor refers to whether a specific protein is present on red blood cells.
Rh positive means the factor is present
Rh negative means it is absent
Together the ABO system and Rh factor create eight common blood types. This information helps researchers characterize donors and design reliable research cohorts.
The Eight Common Blood Types and Why They Matter in Research
Blood type data helps support donor characterization, cohort diversity, and program planning for cell isolation and biomedical research.
O Positive
The most common blood type.
Supports broadly representative donor cohorts and large scale research programs.
O Negative
Less common than O positive.
Often requested for compatibility sensitive research applications or specific program requirements.
A Positive
A common blood type.
Helps support balanced donor representation across research studies.
A Negative
Less common Rh negative blood type.
Important for studies that intentionally include Rh negative donor populations.
B Positive
Less common overall.
Supports donor diversity and inclusion across research programs.
B Negative
One of the rarer blood types.
Valuable for studies requiring representation of less common donor profiles.
AB Positive
A rare ABO blood type.
Useful for building diverse cohorts and supporting stratified research designs.
AB Negative
The rarest of the eight common blood types.
Important for programs that require inclusion of rare donor characteristics.
Blood Type Information and Research Compatibility
In biomedical research and cell therapy development, blood type information may be used to characterize donors, stratify cohorts, and support specific downstream applications.
Matching and compatibility considerations depend on the intended research use and are managed by trained laboratory and clinical professionals when applicable.
How common is each blood type
Blood type distribution varies by population. The percentages below are general estimates used for educational purposes.
O positive about 37%
O negative about 7%
A positive about 36%
A negative about 6%
B positive about 9%
B negative about 2%
AB positive about 3%
AB negative less than 1%
Rare blood types are harder to replace and more difficult to keep available. Donors with uncommon blood types may be contacted more frequently.
How Blood Type Affects Research and Cell Isolation Needs
Cell isolation and biomedical research rely on donor diversity and consistent access to well documented starting material.
Common blood types help build large representative cohorts
Rare blood types ensure population diversity is reflected in studies
Some programs require specific donor profiles for matching or stratification
High quality donor data improves research reliability and reproducibility
Maintaining a diverse donor pool supports both ongoing research and future therapy development.
Blood Types and Biomedical Research
Beyond basic classification, blood type data plays an important role in biomedical research and cell based therapy development.
Donated blood and blood derived starting materials help researchers:
Isolate specific cell populations
Study immune cell variability and function
Develop and test cell based therapies
Build reliable donor cohorts for long term research programs
Well documented donors help advance science and improve future treatments.
Frequently Asked Questions
Which blood types are most needed
Research needs change over time. Both common and rare blood types are important depending on program requirements. All blood types are valuable.
Is my blood type useful for donating
Yes. Every blood type supports research in different ways and contributes to donor diversity.
How often can I donate
Donation frequency depends on donation type, program needs, and individual eligibility.
Can first time donors participate
Yes. First time donors are welcome and guided through each step of the process.
Can my blood type change
Your blood type does not change under normal circumstances.
Is my donation used for transfusions or blood banks
No. Donations through CGT Global are not used for transfusion or routed into the blood bank supply. They are used as starting material to isolate cells for research and cell therapy related programs.
Ready to Donate
Donating through CGT Global supports biomedical research and cell isolation programs that help advance future therapies. Whether your blood type is common or rare, your participation makes a difference.
